Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 50,000 shares at $3.83 ($191,500)
  3. 4 Open-market buy Director bought 50,000 shares at $3.83 ($191,500)
  4. 4 Open-market sale Director sold 100,000 shares at $3.83 ($383,000)
  5. 4 Other acquisition Director acquired 1,600,000 shares (other)
  6. 4 Other acquisition Director acquired 2,431,611 shares (other)
  7. 4 Open-market buy Director bought 2,000 shares at $2.82 ($5,640)
  8. 4 Open-market buy Director bought 75,000 shares at an average $2.80 ($210,067)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 5 Insider Annual Insider Trading Report

Page 14 of 37 · 722 filings